Interviews/Contributions
Investor Insights – Darshana Zaveri: Catalyst Health Ventures’ Focus Area
Investor Insights – Darshana Zaveri: How CEOs should prepare for a meeting with CHV
Investor Insights: Louis Cannon – BioStar Capital and their Focus, Stage, and Typical Investment (part 3)
Investor Insights: Alan Davis – BioStar Capital and their Newly Raised Fund (part 2)
Investor Insights: Louis Cannon, MD of BioStar Capital – why were different (part 1)
Investor Insights: Gwen Watanabe – What Do You Look for in New MedTech Ventures?
McDermott + Bull Partner Ken Dropiewski talks with H.I.G. Capital Managing Director Gwen Watanabe about what her team looks for in prospective partners for new venture opportunities.
Investor Insights: Gwen Watanabe – How Do You See Venture in MedTech Looking in 2023?
McDermott + Bull Partner Ken Dropiewski talks with H.I.G. Capital Managing Director Gwen Watanabe about what she’s expecting to see in the venture capital space in 2023.
Investor Insights: Gwen Watanabe – At What Stage Does H.I.G. Capital Typically Invest?
McDermott + Bull Partner Ken Dropiewski talks with H.I.G. Capital Managing Director Gwen Watanabe about when they typically invest.
A Conversation on Revolutionizing Vascular Surgery + Challenging the Medical Field with Dr. Frank J. Veith
Dr. Frank J. Veith and McDermott + Bull Partner Ken Dropiewski talk about the challenges in getting the medical field to adopt new procedures, the state of the vascular techniques he introduced to the industry, as well as an insider’s […]
Recent
Popular
- No commented posts yet